HK1013420A1 - Molecule labelling using 2-hydraninopyridine derivatives - Google Patents
Molecule labelling using 2-hydraninopyridine derivativesInfo
- Publication number
- HK1013420A1 HK1013420A1 HK98114895A HK98114895A HK1013420A1 HK 1013420 A1 HK1013420 A1 HK 1013420A1 HK 98114895 A HK98114895 A HK 98114895A HK 98114895 A HK98114895 A HK 98114895A HK 1013420 A1 HK1013420 A1 HK 1013420A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pct
- compound
- hydraninopyridine
- derivatives
- date
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Cosmetics (AREA)
- Steroid Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929223168A GB9223168D0 (en) | 1992-11-05 | 1992-11-05 | Improvements in molecule labelling |
PCT/GB1993/002259 WO1994010149A1 (en) | 1992-11-05 | 1993-11-03 | Molecule labelling using 2-hydraninopyridine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1013420A1 true HK1013420A1 (en) | 1999-08-27 |
Family
ID=10724568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98114895A HK1013420A1 (en) | 1992-11-05 | 1998-12-22 | Molecule labelling using 2-hydraninopyridine derivatives |
Country Status (19)
Country | Link |
---|---|
US (1) | US5679778A (ja) |
EP (1) | EP0667859B1 (ja) |
JP (1) | JP3542597B2 (ja) |
KR (1) | KR100295545B1 (ja) |
AT (1) | ATE195730T1 (ja) |
AU (1) | AU676863B2 (ja) |
CA (1) | CA2148595C (ja) |
DE (1) | DE69329293T2 (ja) |
DK (1) | DK0667859T3 (ja) |
ES (1) | ES2150950T3 (ja) |
FI (1) | FI113044B (ja) |
GB (1) | GB9223168D0 (ja) |
GR (1) | GR3034883T3 (ja) |
HK (1) | HK1013420A1 (ja) |
HU (1) | HU226459B1 (ja) |
NO (1) | NO305364B1 (ja) |
NZ (1) | NZ257376A (ja) |
PT (1) | PT667859E (ja) |
WO (1) | WO1994010149A1 (ja) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5942210A (en) * | 1994-11-15 | 1999-08-24 | Cytogen Corporation | Methods for lyoprotecting a macromolecule using tricine |
US5919934A (en) * | 1997-02-19 | 1999-07-06 | The George Washington University | Compounds, compositions, and methods for cancer imaging and therapy |
PL336571A1 (en) | 1997-04-30 | 2000-07-03 | Univ Leland Stanford Junior | Method of in vitro visualising the cellular death |
US6403054B1 (en) | 1997-05-28 | 2002-06-11 | Bristol-Myers Squibb Pharma Company | Ternary ligand complexes useful as radiopharmaceuticals |
US6844333B1 (en) * | 1999-03-26 | 2005-01-18 | The Trustees Of The University Of Pennsylvania | Method of treating atherosclerosis |
US6686461B1 (en) | 2000-03-22 | 2004-02-03 | Solulink Bioscience, Inc. | Triphosphate oligonucleotide modification reagents and uses thereof |
US7102024B1 (en) | 2000-08-01 | 2006-09-05 | Schwartz David A | Functional biopolymer modification reagents and uses thereof |
WO2001070685A2 (en) * | 2000-03-22 | 2001-09-27 | Solulink, Incorporated | Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
JP2004535375A (ja) | 2001-04-03 | 2004-11-25 | テセウス イメージング コーポレーション | 生体内における細胞死の検出および随伴する症状の治療のためのアネキシンの使用方法 |
US6726895B2 (en) | 2001-04-03 | 2004-04-27 | Board Of Trustees Of The Leland Stanford Junior University | Method of imaging cell death in vivo |
GB0130845D0 (en) * | 2001-12-22 | 2002-02-06 | James Peter | Analysis |
US7158353B2 (en) * | 2003-11-06 | 2007-01-02 | Seagate Technology Llc | Magnetoresistive sensor having specular sidewall layers |
WO2006052790A2 (en) * | 2004-11-05 | 2006-05-18 | The Children's Hospital Of Philadelphia | Biodegradable linkers for molecular therapies |
JP5886324B2 (ja) * | 2011-01-31 | 2016-03-16 | アイトゲネシッシェ テヒニッシェ ホーホシューレ チューリッヒEidgenoessische Technische Hochschule Zuerich | 三官能性架橋剤 |
JP6415979B2 (ja) | 2011-06-03 | 2018-10-31 | スリーエム イノベイティブ プロパティズ カンパニー | ヒドラジノ1h−イミダゾキノリン−4−アミン及びこれから調製された複合体 |
CN103582496B (zh) | 2011-06-03 | 2016-05-11 | 3M创新有限公司 | 具有聚乙二醇链段的异双官能连接基以及由其制成的免疫应答调节剂缀合物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4861869A (en) * | 1986-05-29 | 1989-08-29 | Mallinckrodt, Inc. | Coupling agents for joining radionuclide metal ions with biologically useful proteins |
IL93432A (en) * | 1989-02-24 | 1994-02-27 | Johnson Mathey Inc | Hydrazines and hydrazides, their conjugates with macromolecules, and such conjugates labeled with metallic ions |
US5112953A (en) * | 1989-12-29 | 1992-05-12 | Neorx Corporation | Radiolabeled proteins for diagnostic or therapeutic use |
-
1992
- 1992-11-05 GB GB929223168A patent/GB9223168D0/en active Pending
-
1993
- 1993-11-03 PT PT93924157T patent/PT667859E/pt unknown
- 1993-11-03 EP EP93924157A patent/EP0667859B1/en not_active Expired - Lifetime
- 1993-11-03 HU HU9501275A patent/HU226459B1/hu unknown
- 1993-11-03 CA CA002148595A patent/CA2148595C/en not_active Expired - Lifetime
- 1993-11-03 WO PCT/GB1993/002259 patent/WO1994010149A1/en active IP Right Grant
- 1993-11-03 US US08/432,204 patent/US5679778A/en not_active Expired - Lifetime
- 1993-11-03 NZ NZ257376A patent/NZ257376A/en not_active IP Right Cessation
- 1993-11-03 DE DE69329293T patent/DE69329293T2/de not_active Expired - Lifetime
- 1993-11-03 AT AT93924157T patent/ATE195730T1/de active
- 1993-11-03 DK DK93924157T patent/DK0667859T3/da active
- 1993-11-03 JP JP51085194A patent/JP3542597B2/ja not_active Expired - Lifetime
- 1993-11-03 KR KR1019950701810A patent/KR100295545B1/ko not_active IP Right Cessation
- 1993-11-03 AU AU53755/94A patent/AU676863B2/en not_active Expired
- 1993-11-03 ES ES93924157T patent/ES2150950T3/es not_active Expired - Lifetime
-
1995
- 1995-05-04 FI FI952141A patent/FI113044B/fi not_active IP Right Cessation
- 1995-05-04 NO NO951751A patent/NO305364B1/no not_active IP Right Cessation
-
1998
- 1998-12-22 HK HK98114895A patent/HK1013420A1/xx not_active IP Right Cessation
-
2000
- 2000-11-22 GR GR20000402572T patent/GR3034883T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
FI952141A (fi) | 1995-05-04 |
NO305364B1 (no) | 1999-05-18 |
PT667859E (pt) | 2001-02-28 |
EP0667859B1 (en) | 2000-08-23 |
DK0667859T3 (da) | 2000-10-16 |
KR100295545B1 (ko) | 2001-09-17 |
KR950704256A (ko) | 1995-11-17 |
JPH08502744A (ja) | 1996-03-26 |
FI113044B (fi) | 2004-02-27 |
HUT72332A (en) | 1996-04-29 |
DE69329293T2 (de) | 2000-12-28 |
EP0667859A1 (en) | 1995-08-23 |
NZ257376A (en) | 1996-02-27 |
CA2148595C (en) | 2002-05-21 |
AU676863B2 (en) | 1997-03-27 |
WO1994010149A1 (en) | 1994-05-11 |
FI952141A0 (fi) | 1995-05-04 |
JP3542597B2 (ja) | 2004-07-14 |
AU5375594A (en) | 1994-05-24 |
ES2150950T3 (es) | 2000-12-16 |
GB9223168D0 (en) | 1992-12-16 |
ATE195730T1 (de) | 2000-09-15 |
CA2148595A1 (en) | 1994-05-11 |
NO951751L (no) | 1995-06-12 |
NO951751D0 (no) | 1995-05-04 |
HU226459B1 (en) | 2008-12-29 |
GR3034883T3 (en) | 2001-02-28 |
US5679778A (en) | 1997-10-21 |
DE69329293D1 (de) | 2000-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1013420A1 (en) | Molecule labelling using 2-hydraninopyridine derivatives | |
FI914163A0 (fi) | Heterocykliska derivat. | |
EP1006122A4 (en) | PHENYLETHYLENAMIN DERIVATIVES | |
FI903917A0 (fi) | Foerfarande foer framstaellning av med metallradionuklider maerkta proteiner. | |
AU1070895A (en) | Indole-derived arylpiperazines as ligands for 5HT1-like receptors 5HT1B and 5HT1D | |
CA2211385A1 (en) | N-1-carboxyalkyl derivatives of lsd | |
DE50004382D1 (de) | Verfahren zur Herstellung von Guanidinderivaten | |
EP0147181A3 (en) | Thiazolylacetic acid derivatives and their preparation | |
ZA892516B (en) | Process for the preparation of 5-membered nitrogen-containing heteroaromatics | |
KR850007067A (ko) | 옥스아자포스포린 유도체의 염의 제조방법 | |
IN185708B (ja) | ||
KR960704889A (ko) | 인돌리진 유도체의 제조방법 (Process for the preparation of indolizine derivatives) | |
FR2645535B1 (fr) | Preparation d'ethenes substitues | |
KR880000440A (ko) | 사이토르호딘 s유도체, 이의 제조방법 및 약제로서의 이의 용도 | |
KR920004377A (ko) | 피리딘카복실산 아미드 유도체 및 이를 함유하는 약제학적 조성물 | |
KR940014350A (ko) | 신규 1, 6-디아미노 피리미딘-4-티온 유도체 및 이의 제조방법 | |
TW352391B (en) | Novel cyanine dyes, the intermediates and preparation thereof | |
TH16053A (ja) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20131102 |